Vote Scores

Home / Companies / Crinetics Pharmaceuticals, Inc. / 7 Jun 2024

Meeting · year to 30 June 2024363 filers reporting

Crinetics Pharmaceuticals, Inc.: meeting of 7 Jun 2024

Votes reported on Form N-PX, item by item

363 Form N-PX filers reported votes at the Crinetics Pharmaceuticals, Inc. meeting of 7 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 65.8% of reported votes for; 62 filers withheld from or voted against at least one nominee.

599 vote records from 153 filers. 48 of the 152 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

63.4% for1.3% against35.3% other31.6% against management153 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

568 vote records from 360 filers. 34 of the 351 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.

88.1% for9.2% against2.8% other9.7% against management360 filers97.9% for2.1% against0.0% other2.1% against management82,658,535 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

299 vote records from 152 filers. 1 of the 151 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

99.3% for0.7% against0.7% against management152 filers100.0% for0.0% against0.0% against management29,114,135 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
Franklin TempletonForForFor
InvescoSplit or no voteAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganForForFor
Goldman SachsAbstain or withhold *ForFor
PGIM and PrudentialForForFor
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaSplit or no voteForFor
First TrustAbstain or withhold *ForFor
Russell InvestmentsForForFor
NationwideAbstain or withhold *ForFor
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsForForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleNo reportForNo report
BNY MellonAbstain or withhold *ForFor
PrincipalAbstain or withhold *ForFor
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSAbstain or withhold *ForFor
MassMutualForForFor
Janus HendersonForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Lord AbbettAbstain or withhold *ForFor
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Crinetics Pharmaceuticals, Inc. meeting?

363 Form N-PX filers reported votes at the meeting of 7 Jun 2024. On say-on-pay, 34 of 351 voted against management (9.7%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Crinetics Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Crinetics Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Crinetics Pharmaceuticals, Inc. with a meeting date within three days of 7 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.